BUZZ — Viking Therapeutics falls on $275 mln stock, $225 mln convertible deals
* Shares of Viking Therapeutics down 9.6% at $37.65 before the bell on Thurs after securing capital raise * VKTX sells ~7.9 mln shares at $35 for $275 mln gross proceeds; offering price represents 16% discount to stock's last close * It also announces offering of $225 mln 2% convertible bonds (CBs) due Oct 15, 2032; co